Tomas Leanderson

Tomas Leanderson publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Tomas Leanderson sits on this spectrum.

Tomas Leanderson D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Tomas Leanderson sits on this spectrum.

Overview

Best Publications

• Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides

  Per Björk;Anders Björk;Thomas Vogl;Martin Stenström

  472
  Citations

• Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.

  Marina Karaghiosoff;Ralf Steinborn;Pavel Kovarik;Gernot Kriegshäuser

  446
  Citations

• Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria

  Giuseppe Mancuso;Angelina Midiri;Carmelo Biondo;Concetta Beninati

  315
  Citations

• IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

  Ingrid Teige;Alexandra Treschow;Anna Teige;Ragnar Mattsson

  288
  Citations

• Interferon-β is required for interferon-α production in mouse fibroblasts

  Lena Erlandsson;Ralf Blumenthal;Maija-Leena Eloranta;Holger Engel

  254
  Citations

• Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion

  Monika Pruenster;Angela R. M. Kurz;Kyoung-Jin Chung;Xiao Cao-Ehlker

  202
  Citations

• Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation

  Thomas Vogl;Athanasios Stratis;Viktor Wixler;Tom Völler

  195
  Citations

• Antioxidant metabolism induced by quinic acid. Increased urinary excretion of tryptophan and nicotinamide.

  Ronald W. Pero;Harald Lund;Tomas Leanderson

  181
  Citations

• S100A9 Interaction with TLR4 Promotes Tumor Growth

  Eva Källberg;Thomas Vogl;David Liberg;Anders Olsson

  173
  Citations

• Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent.

  Matteo Riva;Eva Källberg;Per Björk;Dora Hancz

  161
  Citations

• Lack of J Chain Inhibits the Transport of Gut IgA and Abrogates the Development of Intestinal Antitoxic Protection

  Nils Lycke;Lena Erlandsson;Lena Ekman;Karin Schön

  161
  Citations

• In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.

  Anette Sundstedt;Mikael Sigvardsson;Tomas Leanderson;Gunnar Hedlund

  156
  Citations

• Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus.

  Anders A. Bengtsson;Gunnar Sturfelt;Christian Lood;Lars Rönnblom

  155
  Citations

• Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors

  Anders Olsson;Anders Björk;Johan Vallon-Christersson;John T Isaacs

  125
  Citations

• Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus

  Helena Tydén;Christian Lood;Birgitta Gullstrand;Andreas Jönsen

  113
  Citations

• Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment

  John T. Isaacs;Lizamma Antony;Susan L. Dalrymple;W. Nathaniel Brennen

  112
  Citations

• Expansion, selection and mutation of antigen-specific B cells in germinal centers.

  Tomas Leanderson;Eva Kallberg;David Gray

  111
  Citations

• Identification of ABR‐215050 as lead second generation quinoline‐3‐carboxamide anti‐angiogenic agent for the treatment of prostate cancer

  John T. Isaacs;Roberto Pili;David Z. Qian;Susan L. Dalrymple

  102
  Citations

• Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models

  Li Shen;Anette Sundstedt;Michael Ciesielski;Kiersten Marie Miles

  100
  Citations

• Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis.

  R F Schelbergen;E J Geven;M H J van den Bosch;H Eriksson

  98
  Citations